Antitumor activity of a folate receptor-targeted immunoglobulin G-doxorubicin conjugate

Development of antibody-drug conjugates (ADCs) is a promising therapeutic strategy for cancer therapy. In this study, folate was conjugated via a polyethyleneglycol (PEG) linker to immunoglobulin G (IgG), which was linked to doxorubicin (DOX), to form a novel ADC folate-PEG-IgG-DOX (FA-PEG-IgG-DOX)....

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Tan, Xu, Ling, Li, Bin, Li, Weijie, Ma, Xiang, Fan, Lingling, Lee, Robert J, Xu, Chuanrui, Xiang, Guangya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383082/
https://www.ncbi.nlm.nih.gov/pubmed/28408821
http://dx.doi.org/10.2147/IJN.S125591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383082/
https://www.ncbi.nlm.nih.gov/pubmed/28408821
http://dx.doi.org/10.2147/IJN.S125591

Ejemplares similares